CURIS, INC. Gain (Loss) on Extinguishment of Debt
CURIS, INC. (CRIS) reported Gain (Loss) on Extinguishment of Debt of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2022-11-09
- CURIS, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- CURIS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was -$890.00K.
- CURIS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- CURIS, INC. gain (loss) on extinguishment of debt for the quarter ending 2020-12-31 was $0.00.
- CURIS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
- CURIS, INC. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
- CURIS, INC. gain (loss) on extinguishment of debt for fiscal 2019 was -$3.50M.
- CURIS, INC. gain (loss) on extinguishment of debt for fiscal 2018 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | -$890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$890.00K derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-K · filed 2022-02-24 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $890.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $890.00K 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-04 | $0.00 10-Q · filed 2021-08-03 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | -$3.50M 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | -$3.50M 10-Q · filed 2020-11-10 | -$3.50M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-04 | -$3.50M 10-Q · filed 2020-08-04 | -$3.50M derived: sum of 3 quarters · filed 2020-08-04 | -$3.50M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | -$3.50M 10-Q · filed 2020-05-12 | -$3.50M derived: sum of 2 quarters · filed 2020-05-12 | -$3.50M derived: sum of 3 quarters · filed 2020-05-12 | -$3.50M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $0.00 derived: sum of 2 quarters · filed 2020-03-19 | $0.00 derived: sum of 3 quarters · filed 2020-03-19 | $0.00 10-K · filed 2020-03-19 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |